PCR Technology Market Size & Analysis Report by Technique, By Product type, By Application, By End-user and By Region – Global Opportunities & Forecast 2021-2028
PCR Technology Market Size & Analysis Report by Technique (Conventional PCR), By Product type (Instruments), By Application (Gene expression analysis), By End-user (Hospitals and diagnostic labs, Healthcare industry, Academia and government organizations, Pharma-biotech companies, Applied industries and Other end users) and By Region
1. Executive Summary
1.1. Key Market Insights
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Regional Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
2.5.1. Research Data
2.5.2. Primary Data
2.5.3. Demand Side and Supply Side Analysis
2.5.4. Market Size Estimation
2.5.5. Research Assumptions
3. Global PCR Technologies Market- Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Market Drivers
3.5. Market Restraints
3.6. Market Trends
4. Global PCR Technologies Market Revenue Forecast till 2028
5. Global PCR Technologies Market by Technique Revenue Forecast till 2028
5.1. Conventional PCR
5.1.1. Real-time PCR (qPCR)
5.1.2. Digital PCR (dPCR)
5.1.3. Reverse Transcription PCR (RT-PCR)
5.1.4. Hot-start PCR
5.1.5. Multiplex PCR
5.1.6. Other PCR
6. Global PCR Technologies Market by Product type Revenue Forecast till 2028
6.1. Instruments
6.1.1. Reagents and consumables
6.1.2. Software and services
7. Global PCR Technologies Market by Application Revenue Forecast till 2028
7.1. Gene expression analysis
7.1.1. Genetic Sequencing
7.1.2. Genotyping
7.1.3. Nucleic acid detection
7.1.4. Nucleic acid synthesis
7.1.5. Standard validation/verification
7.1.6. Diagnostic Applications
7.1.7. Environmental Applications
7.1.8. Other Applications
8. Global PCR Technologies Market by End-user Revenue Forecast till 2028
8.1. Hospitals and diagnostic labs
8.2. Healthcare industry
8.3. Academia and government organizations
8.4. Pharma-biotech companies
8.5. Applied industries
8.6. Other end users
9. Global PCR Technologies Market by Region Forecast till 2028
9.1. North America PCR Technologies Market Revenue Forecast till 2028
(Option 1: As a part of the free 25% customization)
9.1.1. North America PCR Technologies Market by Technique
9.1.1.1. Conventional PCR
9.1.1.1.1. Real-time PCR (qPCR)
9.1.1.1.2. Digital PCR (dPCR)
9.1.1.1.3. Reverse Transcription PCR (RT-PCR)
9.1.1.1.4. Hot-start PCR
9.1.1.1.5. Multiplex PCR
9.1.1.1.6. Other PCR
9.1.2. North America PCR Technologies Market by Product type
9.1.2.1. Instruments
9.1.2.1.1. Reagents and consumables
9.1.2.1.2. Software and services
9.1.3. North America PCR Technologies Market by Application
9.1.3.1. Gene expression analysis
9.1.3.1.1. Genetic Sequencing
9.1.3.1.2. Genotyping
9.1.3.1.3. Nucleic acid detection
9.1.3.1.4. Nucleic acid synthesis
9.1.3.1.5. Standard validation/verification
9.1.3.1.6. Diagnostic Applications
9.1.3.1.7. Environmental Applications
9.1.3.1.8. Other Applications
9.1.4. North America PCR Technologies Market by End-user
9.1.4.1. Hospitals and diagnostic labs
9.1.4.2. Healthcare industry
9.1.4.3. Academia and government organizations
9.1.4.4. Pharma-biotech companies
9.1.4.5. Applied industries
9.1.4.6. Other end users
9.1.5. US PCR Technologies Market All-Up
9.1.6. Canada PCR Technologies Market All-Up
9.2. Europe PCR Technologies Market Revenue Forecast till 2028
(Option 2: As a part of the free 25% customization)
9.2.1. Europe PCR Technologies Market by Technique
9.2.1.1. Conventional PCR
9.2.1.1.1. Real-time PCR (qPCR)
9.2.1.1.2. Digital PCR (dPCR)
9.2.1.1.3. Reverse Transcription PCR (RT-PCR)
9.2.1.1.4. Hot-start PCR
9.2.1.1.5. Multiplex PCR
9.2.1.1.6. Other PCR
9.2.2. Europe PCR Technologies Market by Product type
9.2.2.1. Instruments
9.2.2.1.1. Reagents and consumables
9.2.2.1.2. Software and services
9.2.3. Europe PCR Technologies Market by Application
9.2.3.1. Gene expression analysis
9.2.3.1.1. Genetic Sequencing
9.2.3.1.2. Genotyping
9.2.3.1.3. Nucleic acid detection
9.2.3.1.4. Nucleic acid synthesis
9.2.3.1.5. Standard validation/verification
9.2.3.1.6. Diagnostic Applications
9.2.3.1.7. Environmental Applications
9.2.3.1.8. Other Applications
9.2.4. Europe PCR Technologies Market by End-user
9.2.4.1. Hospitals and diagnostic labs
9.2.4.2. Healthcare industry
9.2.4.3. Academia and government organizations
9.2.4.4. Pharma-biotech companies
9.2.4.5. Applied industries
9.2.4.6. Other end users
9.2.5. UK PCR Technologies Market All-Up
9.2.6. Germany PCR Technologies Market All-Up
9.2.7. France PCR Technologies Market All-Up
9.2.8. Spain PCR Technologies Market All-Up
9.2.9. Rest of Europe PCR Technologies Market All-Up
9.3. Asia-Pacific PCR Technologies Market Revenue Forecast till 2028
(Option 3: As a part of the free 25% customization)
9.3.1. Asia-Pacific PCR Technologies Market by Technique
9.3.1.1. Conventional PCR
9.3.1.1.1. Real-time PCR (qPCR)
9.3.1.1.2. Digital PCR (dPCR)
9.3.1.1.3. Reverse Transcription PCR (RT-PCR)
9.3.1.1.4. Hot-start PCR
9.3.1.1.5. Multiplex PCR
9.3.1.1.6. Other PCR
9.3.2. Asia-Pacific PCR Technologies Market by Product type
9.3.2.1. Instruments
9.3.2.1.1. Reagents and consumables
9.3.2.1.2. Software and services
9.3.3. Asia-Pacific PCR Technologies Market by Application
9.3.3.1. Gene expression analysis
9.3.3.1.1. Genetic Sequencing
9.3.3.1.2. Genotyping
9.3.3.1.3. Nucleic acid detection
9.3.3.1.4. Nucleic acid synthesis
9.3.3.1.5. Standard validation/verification
9.3.3.1.6. Diagnostic Applications
9.3.3.1.7. Environmental Applications
9.3.3.1.8. Other Applications
9.3.4. Asia-Pacific PCR Technologies Market by End-user
9.3.4.1. Hospitals and diagnostic labs
9.3.4.2. Healthcare industry
9.3.4.3. Academia and government organizations
9.3.4.4. Pharma-biotech companies
9.3.4.5. Applied industries
9.3.4.6. Other end users
9.3.5. China PCR Technologies Market All-Up
9.3.6. India PCR Technologies Market All-Up
9.3.7. Japan PCR Technologies Market All-Up
9.3.8. Rest of APAC PCR Technologies Market All-Up
9.4. RoW PCR Technologies Market Revenue Forecast till 2028
(Option 4: As a part of the free 25% customization)
9.4.1. RoW PCR Technologies Market by Technique
9.4.1.1. Conventional PCR
9.4.1.1.1. Real-time PCR (qPCR)
9.4.1.1.2. Digital PCR (dPCR)
9.4.1.1.3. Reverse Transcription PCR (RT-PCR)
9.4.1.1.4. Hot-start PCR
9.4.1.1.5. Multiplex PCR
9.4.1.1.6. Other PCR
9.4.2. RoW PCR Technologies Market by Product type
9.4.2.1. Instruments
9.4.2.1.1. Reagents and consumables
9.4.2.1.2. Software and services
9.4.3. RoW PCR Technologies Market by Application
9.4.3.1. Gene expression analysis
9.4.3.1.1. Genetic Sequencing
9.4.3.1.2. Genotyping
9.4.3.1.3. Nucleic acid detection
9.4.3.1.4. Nucleic acid synthesis
9.4.3.1.5. Standard validation/verification
9.4.3.1.6. Diagnostic Applications
9.4.3.1.7. Environmental Applications
9.4.3.1.8. Other Applications
9.4.4. RoW PCR Technologies Market by End-user
9.4.4.1. Hospitals and diagnostic labs
9.4.4.2. Healthcare industry
9.4.4.3. Academia and government organizations
9.4.4.4. Pharma-biotech companies
9.4.4.5. Applied industries
9.4.4.6. Other end users
9.4.5. Brazil PCR Technologies Market All-Up
9.4.6. South Africa PCR Technologies Market All-Up
9.4.7. Saudi Arabia PCR Technologies Market All-Up
9.4.8. UAE PCR Technologies Market All-Up
9.4.9. Rest of world (remaining countries of the LAMEA region) PCR Technologies Market All-Up
10. Competitive Landscape Analysis
10.1. Porter’s Five Forces Analysis
10.2. Industry – Competitive Landscape
10.3. Market Presence (Intensity Mapping)
10.4. Key Strategic Market Developments
11. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
11.1. Thermo Fisher Scientific India Pvt. Ltd.
11.1.1. Company Overview
11.1.2. Key Executives
11.1.3. Footprint & Employee Strength
11.1.4. Product Offerings
11.1.5. Financials
11.1.6. Key Company Developments
11.2. F. Hoffmann-La Roche Ltd
11.2.1. Company Overview
11.2.2. Key Executives
11.2.3. Footprint & Employee Strength
11.2.4. Product Offerings
11.2.5. Financials
11.2.6. Key Company Developments
11.3. Bio-Rad Laboratories, Inc.
11.3.1. Company Overview
11.3.2. Key Executives
11.3.3. Footprint & Employee Strength
11.3.4. Product Offerings
11.3.5. Financials
11.3.6. Key Company Developments
11.4. QIAGEN
11.4.1. Company Overview
11.4.2. Key Executives
11.4.3. Footprint & Employee Strength
11.4.4. Product Offerings
11.4.5. Financials
11.4.6. Key Company Developments
11.5. Takara Bio Inc.
11.5.1. Company Overview
11.5.2. Key Executives
11.5.3. Footprint & Employee Strength
11.5.4. Product Offerings
11.5.5. Financials
11.5.6. Key Company Developments
11.6. Agilent Technologies, Inc.
11.6.1. Company Overview
11.6.2. Key Executives
11.6.3. Footprint & Employee Strength
11.6.4. Product Offerings
11.6.5. Financials
11.6.6. Key Company Developments
11.7. bioMérieux SA
11.7.1. Company Overview
11.7.2. Key Executives
11.7.3. Footprint & Employee Strength
11.7.4. Product Offerings
11.7.5. Financials
11.7.6. Key Company Developments
11.8. Danaher
11.8.1. Company Overview
11.8.2. Key Executives
11.8.3. Footprint & Employee Strength
11.8.4. Product Offerings
11.8.5. Financials
11.8.6. Key Company Developments
11.9. Abbott
11.9.1. Company Overview
11.9.2. Key Executives
11.9.3. Footprint & Employee Strength
11.9.4. Product Offerings
11.9.5. Financials
11.9.6. Key Company Developments
11.10. Merck KGaA
11.10.1. Company Overview
11.10.2. Key Executives
11.10.3. Footprint & Employee Strength
11.10.4. Product Offerings
11.10.5. Financials
11.10.6. Key Company Developments
12. About GMI Research
*Details on Financials might not be available in case of unlisted/private companies.
*The list of companies is based on preliminary research in this sample report, the companies in the final report may change based on research findings.
- Published Date: Jul - 2021
- Report Format: Excel/PPT
- Report Code: UP2118-001001
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
PCR Technology Market Size & Analysis Report by Technique, By Product type, By Application, By End-user and By Region – Global Opportunities & Forecast 2021-2028
$ 4,499.00 – $ 6,649.00